Storm Therapeutics
About:
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Website: http://www.stormtherapeutics.com
Top Investors: Innovate UK, IP Group, Cambridge Innovation Capital, M Ventures, Pfizer Venture Investments
Description:
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Total Funding Amount:
$69.6M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2015-01-01
Founders:
Eric Miska, Tony Kouzarides
Number of Employees:
11-50
Last Funding Date:
2022-12-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai